The object of this opening paper is to discuss briefly the types of tuberculin in use in human and veterinary medicine, with particular reference to the description of mammalian tuberculins in the British Pharmacopoeia and Pharmaceutical Codex, to the specificity characteristics of various tuberculins and the criteria of specificity needed when man is not the only animal under consideration. The origin of my contribution lies in a discussion with Professor R. E. Glover on the phrasing of a descriptive notice on tuberculins intended for the prospective Veterinary Pharmaceutical Codex, in which I urged that the veterinarian should remain as unshackled by medical tradition as possible and be in no way bound by the B.P. Codex. It also connects with some correspondence with Dr. A. A. Miles on problems
of biological standardization and with a discussion at the Ministry of Health in which I urged the general adoption of P.P.D. Tuberculin in place of O.T. This introduction presents the point of view of a biochemist and is intended as a plea for P.P.D. tuberculins.
TYPES OF TUBERCULIN
In the British Pharmacopoeia and Pharmaceutical Codex two types of tuberculin are recognized, "Old Tuberculin" and "Purified Protein Derivative Tuberculin", but to me, at least, the specifications for each leave much to be desired. Many medical men I have talked to, even specialists on tuberculosis as a disease, seem vague on the chemical nature and relative merits of the products.
(I) Old Tuberculin.-In describing the preparation of O.T. wide latitude is allowed in selection of media for growth, and no particular strain of M. tuberculosis is demanded. It seems to be assumed that the same end-product will be obtained whether the final fluid is evaporated in presence of the micro-organisms or after their removal by filtration, and the statement is made that there is no clear evidence that preparations from human type and bovine type "differ as to their active principle". The specification that the medium should contain 5 % of glycerol, and after growth should be evaporated to one-tenth volume on the water-bath, suggests that a heat-concentrated tuberculin deviating from this mode of manufacture is not entitled to the designation O.T. and could not be dispensed as such. The phrase "if necessary diluted with 50% glycerol" ignores the fact that if dilution is not necessary the finished product may contain hardly any glycerin at all; indeed one substandard supplied from a well-known institute, although equivalent to international standard in potency, showed only 2% glycerol when analysed by the specific periodate technique.
The only point which seems to matter in the B.P. description is that the final preparation must match international standard O.T. in potency, but even then no precise method of assay is insisted upon. It would surely simplify life for manufacturers if O.T. were plainly described as "any witches' brew derived by evaporation of any unspecified fluid medium in which any unspecified strain of mammalian M. tuberculosis had been grown, provided its potency matched that ofanother witches' brew kept in Copenhagen and called international standard, or any allegedly equivalent sub-standard thereof, when tested on an unspecified number of guinea-pigs without worrying too much about statistical analysis of results". I can, if requested to do so, defend this wild suggestion for revision of the B.P., on the basis of chemical analysis and potency tests on a variety of actual specimens bought on the open market as "Old Tuberculin". The potency ranged from one-half to three times international standard, although the one with the highest potency, an American product also sold in this country, seems from its physico-chemical characteristics to have been concentrated by other means than simple heat evaporation. One "tuberculin", not described as an O.T. and not stated to comply with B.P. standard, showed a potency only about one-tenth international standard-a clear indication that no reliable guinea-pig assay had been conducted on it before issue.
It should, of course, be stated that the British Pharmacopoeia (1948, p. 803) does suggest a standardization technique and indicates the, fiducial limits of a properly randomized eight guinea-pig test, but there is no obligation to conform to the suggestion and it is quite certain that some commercial standardizations, in various countries, are very badly conducted.
There is also considerable confusion in the literature on tuberculosis concerning the real potency of various concentrated tuberculins and I have, for example, seen the "heat concentrated synthetic medium tuberculin" (H.C.S.M.) of the Bureau of Animal Industry (B.A.T.) in America described as "quarter O.T.". In point of fact it matches international standard in potency and, indeed, is usually slightly above. The confusion arises by assuming that when a bacterial culture filtrate is evaporated to one-tenth it is concentrated ten times in potency, and that since B.A.I. tuberculin is made by evaporation to one-fifth and subsequently diluted with an equal volume of phenolized glycerol, it can only be one-quarter as potent. Many people engaged in tuberculin production but who are not chemists, either forget or do not know that the process of evaporation of culture filtrate in basins on a steam bath involves extensive denaturation of the active protein principle, and that in filtering off the insoluble debris for final clarification two-thirds of the potent material originally present may be thrown away; also that the process of evaporation may involve extensive oxidation of, and acid production from, the glycerol present. The process of evaporation to one-tenth may concentrate the original potency only two or three times and should therefore be declared wasteful, erratic and obsolete. It does of course concentrate tenfold the unused salts of the original medium and some of the unwanted by-products of bacterial growth, and may provide a final witches' brew from which magnesium ammonium phosphate is liable to crystallize out on storage and necessitate a second clarification. I do not believe that there is anything in the brew which can be claimed to be desirable, apart from the residual tuberculoprotein, and if concentration of active principle is the only object of evaporation it is much easier and cleaner to run the bacterial filtrate through a collodion membrane leaving about a quarter behind, to assay this and dilute to match international standard. Even simpler is it to use an appropriate synthetic medium, determine the tuberculoprotein in the filtrate by chemical analysis and ultrafilter to desired final concentration. The ensuing biological assay then becomes a "formality" provided the strain of organism used is "fixed" and produces tuberculoprotein of known characteristics.
It is also not always realized that the quantity of active principle, apart from its specific biological characteristics, depends a great deal on the strain of organism used, the nature of the medium, and precision in adjusting initial pH. UJsing B.A.I. medium containing 10% of glycerol and 14 % of asparagine, with B.A.I. strains D.T., P.N. and C., and starting at pH 6-8, it is quite easy to obtain a bacterial filtrate after eight weeks' growth which yields 0-7-1-2 grammes of active principle per litre, i.e. is about half international standard in potency without any further concentration. Ufsing a synthetic medium containing only 5 % glycerol, less nitrogenous substrate, and less carefully selected strains, it is equally easy to end with less than one-third of the quantity of active principle. Add to this the obscure perils of evaporating to one-tenth volume on a steam bath in a current of warm air and it is not surprising that the B.P. states that "if the potency of the concentrate is less than that of the standard preparation it is rejected". All these difficulties would be avoided if strain and medium were specified and more suitable methods of concentration adopted. So far as I know nobody has advocated simple ultrafiltration as a means of concentration and the arrival of P.P.D. tuberculins is enough to strangle the suggestion at birth except for any manufacturer who wishes to fake ostensible O.T. preparations, or any research worker who wishes to study the possible biological effects of ultrafiltrable by-products of bacterial growth. I, myself, see no sense in continued use by the medical profession of heat-concentrated tuberculins at all. The "Purified Protein Derivative" types of tuberculin are cleaner, much cheaper to prepare "per tuberculin unit", and much more easily standardized with a high degree of precision. Provided there is no variation in the strain of organism used they can be issued on the basis of an accurate chemical analysis, or on a "weight-volume" basis at any desired potency. Occasional biological tests are then only necessary to guard against unexpected changes in character of laboratory strains of M. tuberculosis (highly unlikely if these are "fixed") either in respect of potency or specificity of the protein derivative produced.
(2) P.P.D. tuberculins. In the British Pharmacopceia and Pharmaceutical Codex descriptive matter, relating only to the hominis variety, no attempt is made to explain what "Purified Protein Derivative" actually is, beyond stating that it is the "active principle of old tuberculin". One sincerely hopes that this is universally accepted as true, because the case for adherence to "Old Tuberculin" by the medical profession in this country is then demolished at one blow. But it ignores the fact that the word "purified" is not the same as "pure" and that even the best P.P.D. preparations on the market, of about 90% tuberculoprotein content, still contain appreciable quantities of polysaccharide and nucleic acid which are not known to be concerned in the intradermal tuberculin reaction at all. These can be removed and a product obtained which can be regarded as 99 % tuberculoprotein, but the 1046 oil cumbersome additional procedure is not justified commercially so long as their presence is not regarded as significant. They make no difference in the intradermal test although the polysaccharide may be of significance when tuberculin is used as an antigen in the hamagglutination test.
The mode of preparation is referred to as a "complex process", although almost the total world production since 1943 has been by an exceedingly simple and cheap process. The statement that "when 5 mg. of the dry powder is dissolved in 1 ml. of a suitable buffer,thepotency of the solution is equivalent to that of the standard preparation of old tuberculin" is most misleading when it is not stated that such a preparation would still be two-thirds inert-material. It should be stated that the simplest and cheapest method of preparation (the Weybridge technique) yields a product (of about 90% purity) such that 2 mg. per ml. matches international standard, and that the reserve standard P.P.D. prepared by Seibert in America (by an unnecessarily elaborate technique) for the World Health Organisation, but apparently never used by that body, was also of that potency. With her product prepared in small quantity as a reference stock, and our own issued in enormous quantities annually since 1943, one "tuberculin unit" is provided by 0X00002 mg. P.P.D. The low standard of the B.P. (0*00005 mg. per unit) has led to some confusion in the literature and products conforming to it hardly deserve the designation "purified" at all. What then is P.P.D. or what are P.P.D.s? The phrase was coined by Seibert in the late thirties for the hominis variety of a purified tuberculoprotein, or mixture of tuberculoproteins of similar nature which she has subsequently characterized more closely, but I myself, a few years later, extended the meaning to other acid-fasts, defined the P.P.D.s as the "water-soluble, nonheat-coagulable, low molecular weight protein fractions contained in the steamed culture filtrate, after growth of Mycobacterium tuberculosis or allied acid-fast organisms in a synthetic medium, approximately purified after precipitation by any protein precipitant subsequently easily removable", and drew attention to the specificity characteristics of protein derivatives of six different acid-fasts including M. tuberculosis, varieties hominis, bovis, BCG, and avium.
The technique for production of "Weybridge P.P.D. tuberculins", devised in 1939 and already in routine use since 1943, was published in The Veterinary Journal in September 1946. It consists in growing fixed laboratory strains in synthetic medium for eight weeks in litre units, steaming to kill the organisms, filtering through paper pulp, precipitating the total protein directly from the clear filtrate with trichloracetic acid (thereby avoiding the denaturation and extravagant losses involved in preparatory heat concentration), washing the precipitate centrifugally with buffered water to remove the trichloracetic acid, and redissolving the wet sludge in phenolized buffer phosphate to provide a storage concentrate of which the protein content can be determined analytically. The concentrate is passed through a Sharples centrifuge to remove unwanted high molecular weight material and diluted to any desired issue strength with glycerinated phenolized buffer phosphate. After passing through Sterilmats the finished tuberculin is restandardized analytically and issued on the basis of mg.P.P.D. per ml. to an accuracy of 1 %.
If wanted in the dry state the Sharples concentrate is reprecipitated with trichloracetic acid, washed aqueously, then once with acetone and finally several times with ether. On drying off the ether with appropriate stirring the P.P.D. is obtained as a fluffy buff-coloured powder easily soluble in alkalinized water. It can be obtained in somewhat less pure form by freeze-drying the wet protein, and in still purer form (99%) by interposing precipitations with metaphosphoric acid to remove residual polysaccharide and with ammonium sulphate to remove nucleic acid, before final washing and drying.
Ordinary routine Weybridge issues now contain 2 mg. ordinary P.P.D. per ml. in the case of the hominis variety. This matches internationalstandard, i.e. contains 100,000 "tuberculin units" per ml. Biological standardization is carried out on guinea-pigs (usually 12) sensitized with organisms homologous to those used in preparing the P.P.D., and is based upon the straight line relationship between diameter of-reaction and logarithm of concentration, between the limits of concentration which give reactions of appropriate character. In over eight years' production on a very large scale, biological standardization has never once contradicted chemical standardization. A 12 guinea-pig test comparing known solutions of P.P.D. and statistically analysed gives results lying between 80 and 130 of standard set as 100. A 50 guinea-pig test brings the fiducial limits within+ 10% 0. If several hundred guineapigs were used the ±1 0% accuracy of ordinary chemical standardization would doubtless be achieved.
SPECIFICITY OF TUBERCULINS AND OF PURIFIED PROTEIN DERIVATIVES
In medical practice infections with Mycobacterium tuberculosis are almost invariably of mammalian origin and infections with non-specific acid-fast organisms, which might confuse the significance of the.Mantoux test, are so rare that little attention has been paid to the specificity characteristics, as distinct from the potency, ofthe tuberculin used. In veterinary practice, however, the problem of avian tuberculosis in and from poultry has to be dealt with, and infection of bovines with acid-fast organisms other than M. tuberculosis bovis, notably with avium and M. johnei is common. It is important to differentiate between them, and the present "Single Intradermal Comparative Test", adopted for official use by the Ministry of Agriculture, uses two tuberculins, mammalian and avian, injected simultaneously a few inches apart in the neck, in ap attempt to sort out cattle with "non-specific" infections which do not matter from an economic point of view, or from that of human health, from bovine infections which induce progressive disease and which it is desired to eliminate. The method of interpretation is empirical and need not be detailed here, but it serves the purpose of reducing the number of animals which would otherwise have to be removed from herds acceptable under the "Attested Herds Scheme", without jeopardizing the efficiency of the test in condemning genuine bovine reactors. A tuberculin, or protein derivative of tuberculoprotein type, prepared from almost any Mycobacterium gives cross reactions on animals sensitized by almost any other, but the degree of reaction is very different with the homologous and heterologous product and it is possible to assign a "specificity number" to each in relation to any type of infection. In coining the phrase "specificity number" I defined it as "the number of units of the heterologous protein derivative required to elicit the same intradermal reaction in infected guinea-pigs as one unit of the homologous protein derivative". In the chart below, taken from the article on "Weybridge P.P.D. Tuberculins" already mentioned, specificity numbers are indicated for a series of Purified Protein Derivatives from six different acid-fasts prepared at the Veterinary Laboratory of the Ministry of Agriculture in 1943. In preparing the data sensitizations were effected by infection with live organisms, simulating the natural disease, in the case of hominis, bovis, and avium. With the other three, non-pathogenic for the guinea-pig, sensitization was effected by injection of massive doses of organisms in oil. These data are intended to be illustrative of the principle underlying the use of "specificity numbers" rather than to provide hard and fast figures, and they have to be interpreted with caution. They refer to "weight units" of particular dry powder P.P.D. preparations. The figure 20 for human P.P.D. on avian sensitized guinea-pigs, or 20 for avian P.P.D. on human sensitized guinea-pigs, refers to the particular P.P.D. powders used, and may vary with the preparation studied. Human P.P.D., so far as is known, is very constant in characteristics and in any case can be biologically standardized, in respect of potency on homologous sensitization, against an arbitrary accepted international standard. P.P.D.s from M. tuberculosis avium, on the other hand, vary widely in characteristics with different strains and there is no international standard of reference. The only standard is the Weybridge one, derived from a highly specific strain D4 and kept in dry powder form for future reference. If this, or any other suitable one, were accepted as an international standard by the veterinary standards committee of WHO it should be possible to express specificity numbers in terms of biological units independently of variation in characteristics of protein derivatives from various strains, or of nature of tuberculins of O.T. type. This should enable the "specificity" of any commercial tuberculin to be expressed independently of its "potency", and of the weight of the supposedly active principle present.
In medical literature one frequently finds the terms "specificity" and "potency" used as if they meant the same thing and a particular product referred to as more specific when in reality it merely contains a greater quantity of active principle. Indeed much of the confusion concerning the relative merits of O.T. and P.P.D. tuberculins arises from this misunderstanding. It should be emphasized that the word "specificity" has no meaning except in relation to infections with Mycobacteria heterologous to the variety from which the tuberculin is made, and perhaps also in relation to the mode of sensitization of the guinea-pigs for test purposes. It would be quite easy to present a series of "tuberculins" in fluid form, specified only by number, which would appear identical when tested on a set of guinea-pigs sensitized to hominis, by diameters of reaction in an intradermal test, but which would be revealed as vastly different when tested homologously, each on guinea-pigs sensitized to the strain from which it was derived.
It might also be possible to present a series of tuberculins of different origin, the specificity numbers of which are different when tested on animals sensitized by infection and on animals sensitized by injection of dead organisms in oil. Certain observations at Weybridge have suggested this, although the data need further elucidation. The allergicstatus of an animal may well vary qualitatively as well as quantitatively according to the mode of sensitization adopted. Even with the same type of sensitization the relationship between diameter of reaction and logarithm of dose may only be linear within certain limits. To me, therefore, the logical method of assaying tuberculins is on homologous sensitizations gained, wherever possible, by infective processes and at a series of dilutions as near as possible to those likely to be used later in the diagnostic procedures for which the particular tuberculin is intended.
In studying the tuberculoproteins of the Mycobacteria generally, or rather the protein fractions analogous to those in tuberculin, it is not possible to adopt natural infective processes to procure sensitization with non-pathogenic species such as M. phlei, and the phrase "specificity number" may therefore have a somewhat doubtful meaning when comparison is made between organisms pathogenic and non-pathogenic for the test animal concerned.
Of recent years the method of sensitizing guinea-pigs with dead tubercle organisms in oil has come into vogue, and is, of course, very convenient since no progressive disease is induced and a large number of guinea-pigs can be sensitized at once and used at any required moment for a long time thereafter; and in some cases dead organisms heterologous to the tuberculin under test have been used. This is only legitimate for work on "specificity" if thorough comparison with sensitization by infection has previously been made. At present the convenient dead organism technique is used at Weybridge to compare "potency" of different batches of P.P.D. known to have been prepared in exactly the same way, human strain issue tuberculin against human strain reserve standard P.P.D. powder, or avian strain D4 issue tuberculin against reserve standard D4 P.P.D. powder, but where "specificity" is in doubt the test is made on guinea-pigs sensitized by infective processes.
This point is important in veterinary usage, particularly in relation to the issue of "mammalian" and "avian" P.P.D. tuberculins for the "single intradermal comparative test" of the Ministry of Agriculture, which relies upon the specificity characteristics of the diagnostic agents to sort out cattle which may safely be left in an attested herd from those which must be removed. Obviously an avian tuberculin of low specificity number would give entirely misleading results and be worse than useless. Whether the point, or indeed the whole question of "specificity" of tuberculins, is or is not of importance in medical usage it would seem at least of scientific interest to explore the possibility of using specific protein derivatives to identify a Mantoux positive as arising from a hominis infection or from an infection with one or other of the recently described "skin tuberculosis" types, such as the Bairnsdale bacillus Mycobacterium ulcerans.
SUMMARY
(1) A plea is put forward for abolition of the use of "Old Tuberculin" by the medical profession and substitution of "purified protein derivative". In veterinary practice such substitution is making rapid headway.
(2) P.P.D. of constant characters, containing about 900% of true tuberculo-protein in the dry state, is easily prepared by the very simple "Weybridge technique". Still higher purification can be accomplished if desired. As ordinarily made it has a potency such that a solution containing 2 mg. per ml. matches international standard Old Tuberculin, i.e. is equivalent to 100,000 units per ml.
Solutions can be accurately standardized by chemical analysis and the wide variations inherent in ordinary biological standardization can be so avoided. Because of the high losses of active principle during heat concentration of media in which M. tuberculosis has been grown "P.P.D. Tuberculin" is much cheaper to manufacture than "O.T."
(3) The specifications, both for old tuberculin and protein derivative tuberculin, in The British Pharmacopoeia and Pharmaceutical Codex are criticized.
(4) The distinction between "potency" and "specificity" is discussed and the meaning of the term "specificity number" is explained.
(5) The use of mammalian and avian P.P.D. tuberculins in differentiating specific from non-specific infections in bovines, under the tuberculosis eradication scheme of the Ministry of Agriculture, is indicated.
REsUMi.-l. La vieille tuberculine devrait etre remplac&e en pratique m6dicale par la tuberculine P.P.D. Ce remplacement fait dej& des progr6s rapides dans la pratique veterinaire.
2. Une P.P.D. presentant des caracteres constants, et contenant environ 90 % de veritable tuberculoproteine A l'etat sec, est facile a preparer par la technique tres simple suivie A Weybridge. Un plus haut degre de purification peut etre obtenu si on le desire. L'activite de cette P.P.D., pr6paree par la methode ordinaire est tellemqu'une solution de 2 mg. par ml. correspond A l'etalon international de vieille tuberculine, c'est-A-dire 100,000 unites par ml.
Ces solutions peuvent etre titr6es exactement par l'analyse chimique, qui 6vite les grandes variations inherentes au titrage biologique habituel. La preparation de la tuberculine P.P.D. est beaucoup moins couteuse que celle de la vieille tuberculine, A cause des fortes pertes de principe actif entrain6es par la concentration par la chaleur des milieux de culture du M. tuberculosis.
3. L'auteur rel6ve les defauts des sp6cifications The accuracy of this assay is difficult to estimate because it is required only that the unknown tuberculin shall be as potent as the Standard; and fiducial limits of error cannot be determined.
Dr. D. A. Long, Dr. W. L. M. Perry and I have devised an assay in 8 guinea-pigs that does not depend on matching similar patterns of reactions produced by the standard and unknown tuberculins, and which yields a numerical estimate of potency and fiducial limits of error of the estimated potency. Wadley (1948, 1949) discovered that the diameter of the intradermal tuberculin reaction in certain areas of the skin of sensitized cows and guineapigs was directly proportional to the logarithm of the dose of tuberculin injected in a constant volume of liquid. We have confirmed this in guinea-pigs sensitized by 2 mg. wet weight of BCG three to six weeks previously; the skin of the trunk posterior to the shoulder blade, anterior to the knee-joint, excepting the thin skin on the ventral aspect of the belly, may be considered. as uniformly sensitive to tuberculin; and the proportionality of log. dose and diameter holds for twenty-four hour lesions ranging from 7 to 25 mm. in diameter. Smaller lesions may be confused with non-specific inflammation, and the erythematous flare accompanying larger lesions makes measurement difficult. Only the diameter is noted for the purpose of this assay: the intensity of the induration and the presence of central necrosis are irrelevant.
The linearity of the dosage-response line over this range holds for Old Tuberculin, the proposed International Standard preparation of P.P.D. made by Dr. F. Seibert, and Dr. J. Bretey's IP48 fraction of the tubercle bacillus; and the slopes of the lines (in one experiment, respectively 3*5, 4 0 and 4'3) are similar. On the basis of these preliminary tests we assume the linearity of the response and perform a (2-+ 2) assay with a high and low dose of standard (SH and SL) and a high and low dose of the unknown tuberculin (UH and IJL). The low doses are selected to give reactions at least 10 mm. in diameter, and the high doses are ten times stronger. Since the slope is about 4, the difference between the mean responses to high and low dose is about 4 mm. The four doses, SH, SL, UH, U-L, are partially randomized on each flank of 8 BCG-sensitized, depilated guinea-pigs and the lesion diameters measured after twenty-four hours.
The analysis of variance of an assay of this kind (Table I) shows that the only significant variance ratios (F) are "between animals", and, as is to be expected, between doses. The parallelism term is not significant, so that it is valid to fit the dosage-response lines of two preparations by a common regression line, and estimate the potency from the horizontal distance between the two fitted lines (Fig. 1; cf. Long and Miles, 1950, Fig. 3 ). In this example, the solution of P.P.D. was equipotent with the solution of Old Tuberculin. It should be noted that though in this example there happens to be an almost perfect "match" of the SH and JH, and of the SL and LfL reactions, it is not necessary, as in methods that depend on matching, to ensure by preliminary titrations that the unknown is equipotent with the standard in the concentration used. It is possible by a single test to assay an unknown whose real potency differs substantially from that of the standard. Since in the analysis of the assay differences in the slopes of the two dosage-response lines can be detected, the presence or absence of a difference can indicate whether Old Tuberculin, P.P.D. and other preparations of tuberculoprotein can in practice be considered similar; that is, whether it is statistically valid to measure the potency of one kind of preparation in terms of another. We have at the present time no right to assume the similarity in this sense of, e.g. Old Tuberculin and P.P.D. (The World Health Organisation has recognized the possible dissimilarity of the two and is creating a separate International Standard for P.P.D.) Dissimilarity, or heterogeneity of the standard or of the unknown preparations used in assay may be revealed by differences in the slope of the dosage-response lines or by differences in the ratio of potencies when the test animal is changed (as, for example, by sensitizing it with a different preparation of tubercle bacilli). If no such differences appear in assay, it is clearly practicable to assay one kind of tuberculoprotein in terms of another. The absence of evidence of heterogeneity, however, does not necessarily indicate similarity, and in such cases the possibility of invalid assays must always be borne in mind.
We have tested the similarity of Old Tuberculin, Dr. Seibert's P.P.D. and Dr. Bretey's IP48 in this manner, using guinea-pigs sensitized by three different antigens-0-5 mg. dry weight dead virulent human tubercle bacilli in paraffin, as used by Dr. H. H. Green at Weybridge; living, moderately virulent human tubercle bacilli, 0-25 mg. wet weight of strain C.N.844, Wellcome Research Laboratory Collection; and 2 mg. wet weight of BCG. There were definite, though not always strong, indications of dissimilarity (Table II) . In the first place the estimated potency per mg. of the other two preparations, expressed in international units of Old Tuberculin, varied with the sensitizing agent. Thus the estimated potency of the P.P.D. was twice as great when the sensitizing agent was changed from BCG to living tubercle bacilli. Secondly, there was a suggestion that the slope changed with the sensitizing agent. Thirdly, with both the human sensitizing antigens, the slope of the IP48 differed significantly from that of Old Tuberculin. The BCG animals gave the most consistent assays, though the estimated potency was low. These results are compatible with the speculation that BCG does not induce sensitivity to all the tuberculous allergens, and that, compared with IP48, the International Standard of Old Tuberculin contains a relatively low proportion of the allergens to which the BCG-sensitized guinea-pig is insensitive. But whatever the explanation, it is clear that current assays of one kind of tuberculin in terms of another are not necessarily valid, and that the results are not independent of the type of sensitizing agent, even among the available bovine or human types of antigen. Moreover, the influence of sensitizing agent in the guinea-pig throws doubt on the safety of assuming that potency in the guinea-pig necessarily reflects the diagnostic potency of a tuberculin in the human subject, who may be sensitized by natural infection or by BCG or allied immunizing agents. Among the diagnostic tuberculoproteins used in man, the range of the estimated potencies obtained from these various methods of assay may however be immaterial, because these reagents are commonly used in coarsely graded doses (cf. the tenfold differences in Mantoux test doses).
But whatever the relevance of these discrepancies to the clinical problem, we contend that the assay we propose serves better than the usual routine assays, both for the estimation of potency ratios, and for discovering when potency estimations are not to be trusted.
SUMMARY.-Potency tests of diagnostic tuberculoproteins usually consist of finding concentrations of the preparation which produce in the sensitized guinea-pig tuberculin skin-reactions of the same size and intensity as those produced by a standard tuberculin. Preliminary titrations may be needed; and only the approximate error of the test can be determined. Taking advantage of the fact that the diameter of tuberculin lesions in the skin of the guinea-pig's flank is proportional to the log. of the dose of tuberculin, a better potency test was devised which, without preliminary titrations, permits a direct comparison of potency of two tuberculoproteins, and an estimation of the fiducial limits of error of the comparison. For a given number of guinea-pigs, the new test gives a great deal more information than the usual tests.
From a consideration of the slope of the dosage-response line, and of changes in the estimated potency of a preparation when the guinea-pigs are sensitized by different antigens (e.g. living or dead tubercle bacilli, or living BCG) it is possible to detect qualitative differences in, for example, Old Tuberculin and P.P.D., and in the specificity of the sensitivity induced by various tuberculous antigens. Such differences may invalidate the assay of one kind of tuberculoprotein in terms of another. REsUME.-L'activite des tuberculo-proteines diagnostiques est generalement determinee par la recherche de la concentration qui produit une reaction cutan&e de meme grandeur et intensite que la r6action produite par une tuberculine etalon chez le cobaye sensibilise. Des titrages preliminaires peuvent etre necessaires. Partant du fait que le diam6t=e des lesions tuberculiniques sur le flanc du cobaye est proportionnel au logarithme de la dose de tuberculine, l'auteur a d6veloppe une meilleure epreuve d'activite, qui permet de comparer directement, sans titrage preliminaire, l'activit6 de deux tuberculo-proteines, et de determiner les limites d'erreur fiducielles de cette comparaison. Pour un nombre donn6 de cobayes, cette nouvelle methode donne beaucoup plus d'information que les epreuves ordinaires. L'inclinaison de la ligne representant la reaction par rapport a la dose et les variations de l'activit6 d'un produit selon l'antigene employ&e pour la sensibilisation du cobaye (bacilles tuberculeux vivants ou morts, BCG vivant) permettent de constater d'une part des differences qualitatives entre, par exemple, la vieille tuberculine et la P.P.D., et, d'autre part, des differences de sp6cificit6 et de sensibilite suivant l'emploi des divers antigenes. Des variations de ce genre peuvent vicier l'essai d'une tuberculo-prot&ine en fonction d'une autre.
Dr. J. Bretey, Institut Pasteur, Paris: New Methods ofPurifying Tuberculin Many methods have been suggested for the purification of tuberculin. The best has so far seemed to be that of Long and Seibert for the preparation of P.P.D. This contains a large proportion of bacillary proteins, but impurities are always present, and the authors have been unable to eliminate them completely.
Workon the fractioning of this P.P.D. tuberculin has resulted in the isolation of two polysaccharide fractions (I and II) and three protein fractions, only two of which (A and B) have tuberculin activity, C being inactive. Apart from fractions If and C, which are of no interest from our present point of view, no fraction has been obtained in a pure state, as is well shown by the electrophoretic curves.
With A. Lamensans, we have perfected a quite different technique of purification, which seems to us to have great advantages.
The starting point is eight-week cultures on Sauton's medium, sterilized by heating for an hour at 1100 C. and filtered. When a precipitate is produced in these filtrates, brought to pH 4.4, all the tuberculin substances are carried with this precipitate by adsorption. We first used a benzoic acid precipitate, as Gough did in his similar experiments. Later we turned to salicylic acid, which has very distinct advantages over benzoic acid.
It is dissolved to a concentration of 5 % in the filtrate, and hydrochloric acid is added to make the pH 2-5-3 5. The salicylic precipitate containing the active principles is isolated by filtration, washed, dried, and finally treated with acetone, which both dissolves the salicylic acid and precipitates the tuberculin substances. These are collected by centrifuging, washed several times in anhydrous acetone and dried in a vacuum. The powder thus obtained is dissolved in distilled water, at a neutral reaction, and the tuberculin is precipitated by 96 % alcohol. After repeated washing with alcohol, and afterwards with anhydrous acetone, the precipitate is dried in a vacuum. This precipitate is "fP48" tuberculin, which is in the form of a creamy white powder, soluble in water at a neutral reaction. Nearly 100 samples of this tuberculin have been prepared, starting from 10 bovine and human strains, virulent or not. Their nitrogen contents differ very little, being between 8-5 and 9-5%, and their activities in cutaneous tests are perfectly comparable.
This method therefore gives a more uniform product than the others, and its rapidity makes it possible to work in strictly aseptic conditions. It is therefore unnecessary to work with a refrigerator or to add antiseptics, and the whole preparation can be finished in a day. Moreover, the risk of denaturing the proteins is very much reduced.
Biologically, this tuberculin gives reactions exactly similar to those given by Old Tuberculin, taking the form of sharply circumscribed cedema, accompanied by erythema of approximately the same diameter. Reading the results is possible without any ambiguity. The activity of this tuberculin is such that one international unit corresponds practically to 0 000020 mg.
Starting from this product, we have, with A. Lamensans and P. Grabar, made attempts to purify it, and have obtained various fractions, two of which are especially interesting. Tuberculin 1P48 is treated with 90% phenol. In this way a soluble part and an insoluble part are obtained.
The insoluble part, St, consisting mainly of polysaccharides, also contains nucleic acids as impurities. This unpurified fraction has infinitely less tuberculin activity than the soluble fraction. Whether purified or not, it constitutes the specific antigen of the hxemagglutination reaction in tuberculosis, described by Dubos and Middlebrook. The further purification of this St fraction has been carried out by P. Grabar. He was able to obtain a product containing 0 42% nitrogen, and perfectly homogeneous on electrophoresis.
Electrophoretic analysis, a study of the adsorption spectra in the ultraviolet range, and chemical investigation have made it possible to follow the course of the purification of this fraction.
The part which is soluble in phenol is fractioned by alcohol. The precipitates obtained with increasing quantities ofalcohol are isolated by centrifuging, washed several times in anhydrous alcohol, and finally dried in a vacuum. In this way we have obtained fractions corresponding to concentrations of alcohol ranging from 9 to 72 %. The most interesting of these, the Pt fraction, consisting of tuberculin proteins, is obtained when the concentration of alcohol exceeds 340
It contains from 14-3 to 1477% of nitrogen, and does not give the reactions for sugars.
On electrophoresis it appears to be homogeneous, but the diagram spreads, which suggests polydispersion. This hypothesis was confirmed by ultrafiltration through a membrane which allowed the passage of fairly small molecules only. This fraction is biologically very active, for the international unit corresponds to 0-0000125 mg. of the powder. It does not sensitize guinea-pigs even after seven injections of 0-01 mg., and the same thing has been found to apply to man.
The reactions are absolutely specific, and have all the characteristics of those produced by Old Tuberculin. If large doses are injected, the reactions cause much less pruritus or pain than those produced by equivalent doses of P.P.D., and they seldom become vesicular. The Pt fraction is completely inactive when used as antigen in the hemagglutination reaction.
It therefore has very constant chemical properties, even when different strains are used as the starting point. It produces biological reactions.much mo6e like those given by Old Tuberculin than do other purified tuberculins. We attribute this to the fact that the technique used causes little change in the active substances, and isolates them in a form approaching their natural state.
